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Abstract. This study aimed at identifying the frequency 
of two blood group antigens of interest within the Colton 
(Co) blood group system, Coa and Cob, the higher and lower 
prevalence antigens respectively. The antigenic frequency 
was determined using the polymerase chain reaction-allele 
specific primer extension (PCR-ASPE) technique on a 
sample size of 68 adult Maltese blood donor samples and 
351 neonatal cord blood samples. The aforementioned 
methodology enabled the molecular typing of the missense 
variant in the aquaporin 1 (AQP1) gene (NM_198098:c.134C>T; 
rs28362692), responsible for the single amino acid change 
of Ala45Val (alanine for Coa and valine for Cob at position 
45) (NP_932766:p.Ala45Val) within the AQP1 protein chain. 
As a result of the missense variant, the Colton phenotypes 
Co(a+b-), Co(a+b+) and Co(a-b+) could be identified 
through the stipulated PCR-ASPE technique, and the rare 
phenotype, Co(a-b+), if detected, would also be subjected 
to DNA sequencing. Analysis of raw data unveiled that the 
Co(a+b-) phenotype was the most prevalent in both the 
donor pool (88.23%) and the cord blood pool (86.04%), whilst 
the Co(a+b+) phenotype revealed a lower occurrence in the 
donor pool (5.88%) and the cord blood pool (6.98%). The 
Co(a-b+) was not encountered in the donor and cord blood 
samples tested, negating the need for DNA sequencing. 
The novelty of this study can be seen in the unprecedented 
determination of the frequency of the Coa and Cob antigens 
within the Maltese population. Outlining the Colton blood 
group antigen frequencies is a significant step to understand 
any susceptibilities to the development of the pertinent 
antibodies, thus aiding in the reduction of Haemolytic 
Transfusion Reactions (HTRs) and Haemolytic Disease of 
the Foetus and Newborn (HDFN). Moreover, research of this 
calibre would expand the local database of molecular typing 
of blood group antigens, improving transfusion.
Keywords: Blood group, Colton system, AQP1, missense 
variant, genotyping, antigen frequency.
1 INTRODUCTION
Red cell antigens play a vital role in transfusion medicine, 
with their attributable polymorphic characteristics that 
render them alloantigenic, indicating the presence of blood 
group activity. Such a feature has the capacity to stimulate 
alloantibody production in individuals who lack the pertinent 
antigens. Transfusion medicine studies value the generation 
of alloantibodies due to the potentially detailed output 
apropos of the red cell surface architecture (Daniels 2007). 
The clinical significance of particular alloantibodies is 
further outlined in reported cases of Haemolytic Transfusion 
Reactions (HTR) and Haemolytic Disease of the Fetus and 
Newborn (HDFN), which indicate that the alloantibodies in 
question were causative of such adverse reactions of varying 
severity (Halverson & Peyrard 2010).
A total of 35 blood groups exist, which are categorised 
into protein-based groups, such as the Colton (Co) blood 
group system, or carbohydrate-based groups, such as the 
ABO blood group system (Daniels 2007). The types of blood 
groups present in an individual, and by extension, the type 
of alleles that influence antigen production of said blood 
groups are inherited from maternal and paternal origins 
(Dean 2005).
With respect to the Colton blood antigens, Preston et 
al. (1994) maintain that studies on the protein aquaporin 
1 (AQP1), a water-channel protein located on the red cell 
membrane, have resulted in its correlation to such antigens. 
The Co antigens are in fact produced by the alleles of the 
same gene that produces AQP1 protein. The first antigen 
to be discovered was Coa (Heisto et al. 1967), followed by its 
antithetical antigen Cob (Giles et al. 1970). Ancillary antigens 
are Co3 and Co4 (Preston et al. 1994), which for the purpose of 
the study were not included. The antibodies corresponding 
to the Co antigens often belong to the immunoglobulin G 
(IgG) class (Daniels 2002; Issitt & Anstee 1998), with some 
anti-Coa, – Cob and – Co3 binding complement (Covin et al. 
2001).
In fact, anti-Coa has been reported as a causative factor 
to significant delayed or acute transfusion reactions or 
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HDFN (Simpson 1973; Kurtz et al. 1982) and anti-Co3 as 
causative factor to HDFN of great severity, necessitating 
neonatal transfusion (Savona-Ventura, Grech & Zieba 1989). 
Conversely, anti-Cob was rarely encountered, and if so, in 
the presence of other alloantibodies in patient’s sera, with 
reports indicating that no significant HDFN was observed 
(Daniels 2002; Issitt et al. 1998).
The molecular point of interest in Co is the alanine amino 
acid at position 45 and a cytosine (C) nucleotide at base 
pair (bp) position 134 in the Coa, and the valine amino acid 
at position 45 and a thymine (T) nucleotide at bp position 
134 in the Cob. The Colton blood group displays a type of 
missense variant, the single nucleotide polymorphism 
(SNP) also known as Coa/Cob SNP, which arises from a single 
amino acid substitution of alanine to valine at position 
45 (NP_932766:p.Ala45Val) caused by the nucleotide 
change of C>T at position 134 in exon 1 of AQP1 gene 
(NM_198098:c.134C>T; rs28362692). The AQP1 protein 
architecture is also indicative of the presence of the SNP 
– in fact, this multi-pass protein, containing a number of 
extracellular and intracellular loops, has the Coa/Cob SNP 
on its extracellular loop (extracellular loop A). Apart from 
this, Colton blood group activity within the AQP1 protein 
structure is correlated to the presence of consensus motifs 
of amino acid sequences asparagine-proline-alanine (Asn-
Pro-Ala). Furthermore, the motif instigates water channel 
formation to an electrostatic field, which is attributed to the 
AQP1 protein function (Halverson & Peyrard 2010).
The phenotypic expression of the Co blood group system 
was highlighted in a study conducted by Lewis et al. (1977). In 
this study, Co blood group phenotypes and allele frequencies 
were derived from a sample size of 726 random Canadian 
Caucasian adults, with an inheritance in 57 unrelated 
families, with at least one Cob-positive parent. It was reported 
that the homozygous wildtype phenotype Co(a+b-) had an 
observed occurrence of 89.81% (n=652); the homozygous 
alternative phenotype Co(a-b+) had an observed occurrence 
of 0.41% (n=3); and the heterozygous phenotype Co(a+b+) 
had an observed occurrence of 9.78% (n=71). The constituent 
codominant alleles, Coa and Cob which respectively give rise 
to the Coa and Cob antigens present on the red cell surface, are 
manifested in the abovementioned phenotypes (Halverson & 
Peyrard 2010) An analysis by Rogers, Stiles & Wright (1974) 
reported the presence of the null phenotype Co(a-b-), which 
could be attributable to varied possibilities of molecular 
alteration, such as a large deletion affecting most of exon 
1 or a 113C>Tpolymorphism on the cDNA (complementary 
DNA), amongst others (Preston et al. 1994). 
In light of the phenotypic occurrence defined by the 
previous studies, the incumbent study aimed at determining 
the frequency of the Coa and Cob antigens and the prevalent 
phenotypes in the Maltese population. This was conducted 
by testing for the characteristic missense variant Coa/Cob 
SNP in 351 neonatal cord blood samples and 68 Maltese 
blood donor samples by polymerase chain reaction-allele 
specific primer extension (PCR-ASPE).
The clinical significance in determining the frequency 
of Coa and Cob antigens is bolstered by the production 
of alloantibodies, which has reportedly led to adverse 
reactions HTR and HDFN (Halverson & Peyrard 2010). This 
unprecedented research on the local scenario of the Colton 
blood group system would therefore contribute to safer 
transfusion practices and better transfusion medicine.
2 METHODOLOGY
2.1 Ethical Approval & Sample Selection
A total of 351 neonatal cord blood samples, obtained from 
the Malta Biobank at the Laboratory of Molecular Genetics 
at the University of Malta, and 68 Maltese blood donor 
samples were obtained from the Hospital Blood Bank at 
Mater Dei Hospital. It was permissible for the latter samples 
to be used for laboratory tests, without a permission form 
from the donors, due to a binding agreement in the National 
Blood Transfusion Service (NBTS) questionnaire. Permission 
was granted to utilise the cord blood samples (reference 
number: 48/2002) and the donor blood samples (reference 
number: 17/2016) by the University of Malta Research Ethics 
Committee.
2.2 DNA Extraction
DNA extraction of a volume of 1 mL donor whole blood 
was the first step taken in the methodology in order to 
achieve downstream application of molecular methods. The 
salting out technique (Miller, Dykes & Polesky 1988) was 
employed to obtain purified DNA for further testing. The 
underlying principle involves the disruption and digestion 
of the preliminary cell membrane, the exposure to a highly 
saline environment, the separation of protein precipitate 
from DNA-laden supernatant by centrifugation, and DNA 
collection through precipitation- inducing solutions such as 
ethanol (Diego & Lyn 2014).
This was carried out by: (i) thawing the whole blood stored 
at – 20oC, at room temperature for approximately one hour on 
a rotator machine (ii) incubating an aliquot of 1mL blood in 
3mL of 1x Erythrocyte lysing buffer (ELB) (84.5g/L NH4Cl; 
10.0g/L KHCO3; 0.3722g/L Na2EDTA) for 15 minutes, and 
centrifuging at 2500g for 10 minutes at 5oC; (iii) discarding 
the supernatant and washing the remaining white cell pellet 
with 1mL of 1x ELB and centrifuging as before (this step was 
repeated to procure a clean pellet); (iv) re-suspending the 
pellet with 1mL 1x Sodium Ethylenediaminetetraacetic acid 
(EDTA) (SE) buffer (43.9g/L NaCl; 93.1g/L Na2EDTA; 1% 
Sodium Dodecyl Sulfate; 1µL proteinase K); (v) incubating 
the tubes overnight in a water bath at 37oC; (vi) adding 1mL 
of 1x SE buffer, 750µL of 6M NaCl and 3.75mL of chloroform 
to the tube, rotating the tubes and intermittently vortexing 
them; (vii) centrifuging the mixture for 10 minutes at 2000g 
and aspirating the top aqueous DNA layer into another tube; 
(viii) mixing the DNA layer with double the volume of 100% 
ethanol to precipitate the DNA strand; (ix) purifying the 
resultant DNA strand with repeated washes of 1mL of cold 
75% ethanol and centrifugation at 11,000g for 4 minutes; 
(x) decanting the mixture and allowing the extracted DNA 
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to air dry; and (xi) resuspending the DNA pellet in 500 µL 
Tris-acetate EDTA (Tris-hydrochloric acid; 0.5M EDTA; 
pH 8.0), leaving the sealed DNA tubes to rotate overnight, 
subsequently being refrigerated at 4oC.
The quality of the samples was noted during the gel 
electrophoresis process through the visualisation of gels 
under an imaging system. Extracted DNA was also quantified 
and checked for its purity with the Nanodrop 2000c UV-
VIS (ultraviolet-visible) Spectrophotometer (Thermo 
Scientific™, USA)
2.3 DNA Quality Checks and Quantification
DNA quality checks were carried out by means of gel 
electrophoresis, and revealed that 37 out of the original 105 
donor samples and 63 out of the original 414 cord blood 
samples were of poor integrity. The nature of their integrity 
would have been detrimental to the interpretation of the 
results and thus had to be removed from the final sample 
size, accounting for the 68 donor samples and 351 cord blood 
samples used for testing. Moreover, quantification of DNA 
showed that the DNA samples were highly concentrated 
(indicating the need for the dilution of samples) and the 
majority exhibited high purity due to their approximate 
value of 1.8 in the 260/280 DNA purity ratio (Matlock 2015).
2.4 PCR-ASPE
PCR-ASPE enables the identification of SNPs through 
an allele-specific single reaction under standard PCR 
conditions. Key components of the PCR-ASPE are its 
primers; the common reverse primer, two forward allele – 
specific primers with different tails and the primer that serves 
as an internal control. The main stages of this technique 
involve: the denaturation of the double stranded DNA, the 
annealing of allele-specific different-tailed primers to their 
complementary DNA sequence and their amplification into 
allele-specific PCR products of varied lengths. The products 
are subsequently separated by gel electrophoresis for an 
enhanced visualisation of the results (Gaudet et al. 2009).
The following primers were used for the purpose of the 
study: Coa forward primer (5’-GAA CAA CCA GAC GGC – 3’), 
Cob forward primer (5’-GGG AAC AAC CAG ACG GT-3’), a 
common reverse primer (5’-CTG AGA GGA TGG CGG TGG-
3’) (Jungbauer 2012), and as an internal control, a human 
growth hormone (HGH) forward primer (5’-GCC TTC CCA 
ACC ATT CCC TTA-3’) and a HGH reverse primer 5’-TCA 
CGG ATT TCT GTT GTG TTT C-3’) in order to ascertain 
that the PCR run was carried out in the correct manner 
(Xuereb, Debono & Borg, 2015). The primers were prepared 
and reconstituted prior to the master mixes preparations 
for the detection of Coa and Cob. The constituents and their 
pertinent volume both can be found in the Table 1.
Table 1: Coa and Cob master mixes (volume in µL)
Reagents Coa Master mix Cob Master mix
5x FIREPol® Master Mix Ready to Load 4 4
Sterile water 14.8 14.8
Forward HGH primer 0.1 0.1
Forward Coa primer 0.1 N/A
Forward Cob primer N/A 0.1
Reverse HGH primer 0.1 0.1
Reverse Co primer 0.1 0.1
For the purpose of this study, 96-well PCR plates were used, 
with the first 48 wells being used for the detection of Coa and 
the second set of 48 wells being used for Cob detection using 
the same samples. The same 48 samples of cord blood or 
donor samples were used for the detection of both antigens.
The volume of Coa and Cob master mixes were multiplied by 
55, to account for the volume required for the 48 wells used 
to detect Coa and Cob, as well as an extra 7µL to overcome 
pipetting errors. Therefore, the total volume of 5x FIREPol® 
Master Mix Ready to Load was 220 µL, sterile water 814 
µL, forward HGH primer 5.5 µL, forward Coa primer 5.5 µL, 
forward Cob primer 5.5 µL, reverse HGH primer 5.5 µL and 
reverse Co primer 5.5 µL.
Wells D12 and H12 were used as negative controls, whereby 
they solely contained the master mix. PCR optimisation 
was an essential step to ascertain proper interpretation of 
the bands on the agarose gel, thus avoiding the presence of 
hindering non-specific secondary bands. This was tackled by 
optimising the annealing temperature by means of gradient 
PCR, which sought to test the effect of varying annealing 
temperatures ranging from 55–65oC within the same run. 
By means of the Mastercycler® thermal cycler (Eppendorf 
s.r.l, Germany), a finalised profile was established through a 
system of trial and error, as seen in Table 2.
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Table 2: Thermal cycler profile for the PCR-ASPE detection of Colton antigens
Number of cycles Temperature (°C) Duration Stage
1 cycle 95 5 minutes Initial hot-start
28 cycles 95 50 seconds Denaturation
62 30 seconds Annealing
72 45 seconds Extension
1 cycle 72 10 minutes Final extension
1 cycle 4 hold Incubation
2.5 Agarose Gel Electrophoresis
The PCR products generated by the PCR-ASPE process 
were then separated by agarose gel electrophoresis. Such 
a method separates DNA by size, depending on their rate 
of migration, through the gel across the electric field, 
facilitating the movement of negatively-charged molecules 
towards the anode electrode (Yilmaz, Ozic & Gok 2012).
A 1.5% agarose gel was prepared (Yilmaz et al. 2012) and 
an aliquot of 7μL of PCR product was subsequently pipetted 
into each well, with the final well being used to load 7μL 
of 100bp DNA ladder. Each gel would contain 48 loaded 
samples to be tested for the presence of either Coa or Cob. 
The gel electrophoresis run was set at 130V for 20 minutes 
with variable current. The gel was subsequently visualised 
by means of UV-transilluminator Bio – Doc-It®2 imaging 
system (Analytic Jena, Germany).
Should Co antigens be present, the Coa would manifest 
itself as a band of 221bp, whilst the Cob would be depicted by 
a band of 223bp (Jungbauer 2012). As established in previous 
studies the internal control HGH would be seen as a band of 
434bp. Since the Colton products are much smaller than the 
HGH products, the bands of the former would migrate at a 
faster rate than the latter (Yilmaz et al. 2012).
3 DATA ANALYSIS
The IBM SPSS® Statistics 20 package was predominantly 
used on the compiled dataset to generate frequency tables 
and bar charts, and perform Pearson Chi-Square tests. The 
frequency tables and bar charts were required to determine 
the genotypic frequencies of the donor and cord blood 
populations in relation to each other, as well as within each 
respective population, separated by phenotype as well as by 
gender. The data extracted from the aforementioned tests 
would be extended to the manual calculation of the allelic 
frequencies. The Pearson Chi-Square tests were used to 
deduce a relationship between the following variables: the 
homozygote wildtype Co(a+b-) and the heterozygote Co(a+b+) 
phenotype within the donor and cord blood populations; 
and the phenotypic differences between males and females 
within the cord blood (or donor) populations. Moreover, the 
Online Encyclopaedia for Genetic Epidemiology Studies was 
used to access the Hardy-Weinberg Equilibrium calculator 
(Rodriguez, Gaunt & Day 2009), in order to determine 
whether genetic and allelic frequencies both the cord and 
donor populations are constant, reaching Hardy-Weinberg 
equilibrium.
4 RESULTS
4.1 PCR Products on Agarose Gel
The electrophoresis gel in Figure 1 indicates the presence 
of HGH (434bp) and Coa (221bp) positive bands, which 
were visible in the majority of lanes on the gel, and were 
measured against the 100bp DNA ladders found in lanes 
25 and 50 and the negative control present in lane 47. The 
electrophoresis gel in Figure 2 demonstrates the presence 
of HGH (434bp) and the predominant absence of strong 
Cob results. In fact, a rarer strong positive Cob result can be 
seen in lane 28, measured against the 100bp DNA ladder 
(lanes 25 and 44). The negative control in lane 42 served as 
a vital measure in order to evade the misinterpretation of Cob 
bands. Both Figures 1 and 2, demonstrated the presence of 
primer dimers, which are the result of secondary reactions 
between the primers themselves, depicted as the third (and 
last) band. Primer dimers stand out in all lanes of the first 
gel, whilst in the second gel, the bands, albeit fainter, are 
also seen in all lanes. Moreover, negative results were also 
observed, indicating a problem with the viability of the 
particular samples tested. For instance, lane 44 in Figure 1 
and lanes 12, 16 and 17 in Figure 2 are prime examples of 




Figure 1: Gel electrophoresis depicting Coa positive results. Top row lanes 1–24 indicate the consistent 
presence of the HGH internal control at 434 bp and the Coa bands at 221 bp, measured against a 100bp DNA 
ladder in lane 25. Bottom row lanes 26–43 indicate a similar consistency, with a few lanes depicting weaker 
results, such as lanes 33,36 and 37. Lane 44 indicates a negative result due to an unviable sample, lane 47 
represents the negative control, lanes 48–49 are empty, and lane 50 represents the 100bp DNA ladder. This 
image also denotes the presence of primer dimers (secondary reaction) in all lanes.
Figure 2: Gel electrophoresis depicting Cob positive results. Top row lanes 1–24 display an array of very 
faint, equivocal Cob results, and the HGH internal control at 434bp, as seen in lanes 1–11, 13–15, 18–21 and 
23, measured against the 100bp DNA ladder in lane 25. Failed samples due to sample unviability can be 
seen in lanes 12, 16–17, 22 and 24. Bottom row lanes 26–44 indicate a strong positive Cob result at 223bp in 
lane 28, faint equivocal Cob results in lanes 26–27 and 29–41, the HGH internal control at 434bp, a negative 
control in lane 42, an empty well in lane 43 and a 100bp DNA ladder in well 44. This image also denotes the 





5.1 Genotypic and Allelic Frequencies
SPSS frequency tables were generated in order to calculate 
the genotype count and percentage occurrence for both 
sample populations and their respective gender segments of 
the homozygous wildtype Co(a+b-), heterozygote Co(a+b+). 
The homozygous alternative Co(a-b+) phenotype was not 
encountered in both populations (0% genotype occurrence), 
and was therefore omitted from the calculations found in 
Table 3. Table 3 also demonstrates the allele frequencies, 
which were calculated by taking into account the co-
dominant alleles Coa and Cob, and Coab for both the donor 
and cord blood populations.
Table 3: Genotypic and allelic frequencies of the donor and cord blood study populations.
Phenotypes Sample Genotype Count Genotype Occurrence (%)
Co(a+b-) Donor population 60 88.2
Males 33 86.8
Females 27 90.0
Co(a+b+) Donor population 8 11.8
Males 5 13.2
Females 3 10.0
Co(a+b-) Cord blood population 302 86.0
Males 157 86.3
Females 145 85.8
Co(a+b+) Cord blood population 49 14.0
Males 25 13.7
Females 24 14.2
Allele Number* Sample Allele frequency** Allele occurrence (%)*** 
Coa 120 Donor population 0.94 94
Coab 8
Cob 0 0.06 6
Coa 604 Cord blood population 0.93 93
Coab 49
Cob 0 0.07 7
5.2 Chi-Square test & Hardy-Weinberg 
equilibrium (HWE)
The SPSS statistical package was also used to conduct 
the Pearson Chi-Square (χ2) test – a test used to deduce 
whether there was a relationship between the following sets 
of categorical variables: (i) occurrence of Co blood group 
phenotypes in cord blood population and occurrence of Co 
blood group phenotypes in donor population; (ii) occurrence 
of Co blood group phenotypes in males and occurrence of 
Co blood group phenotypes in females within the cord blood 
population; (iii) occurrence of Co blood group phenotypes 
in males and occurrence of Co blood group phenotypes in 
females within the donor population. The phenotypes used 
for statistical analysis were Co(a+b-) and Co(a+b+) since 
Co(a-b+) was not encountered. Table 4 represents the 





Table 4: A cross-tabulation of the χ2 analysis performed on the test variables.
Variables Value df Asymptotic significance (2 sided)
p.Ala45Val1*Population2 .234a 1 .629
p.Ala45Val*Gender3 .016b 1 .900
p.Ala45Val*Gender4 0.161c 1 .688
df = degrees of freedom
* = The relationship between the two tested variables
1 = The protein name p.Ala45Val was used as the umbrella 
term for the Co(a+b-) and Co(a+b+) phenotypes
2 = Population refers to the donor and cord blood population
3 = Gender of the cord blood population
4 = Gender of the donor population
a = 0 cells (.0%) have expected count less than 5. The 
minimum expected count is 9.25
b = 0 cells (0.0%) have expected count less than 5. The 
minimum expected count is 23.59
c = 2 cells (50.0%) have expected count less than 5. The 
minimum expected count is 3.53
With reference to the primary χ2 analysis between the two 
Co blood group phenotypes within cord blood and donor 
population, the value of the test statistic is 0.234, the 
p-value is 0.629 and the degrees of freedom is 1 with a level 
of significance of 0.05. Since the p-value is greater than 
the level of significance, there is no statistical difference 
between phenotypes within the two population samples, 
thus indicating similar phenotypic frequencies in the donor 
and cord blood samples. Furthermore, the cross-tabulations 
of the Co blood group phenotypes and the gender reveal 
that the p-value in the case of the cord blood population 
and the donor population is greater than the 0.05 level of 
significance (0.900 in cord blood sample and 0.688 in donor 
samples).
A result of this nature ascertains that there is no 
statistical difference in phenotypic occurrence in males 
and females of both the cord blood and donor population. 
Donor and cord blood samples were also tested for HWE 
(Hardy-Weinberg Equilibrium) by means of the online HWE 
calculator (Online Encyclopaedia for Genetic Epidemiology 
2008). The resultant outcome, expressed as a p-value, 
would in fact verify or negate a statistical difference between 
expected and observed values of the genotypic frequencies, 
thus determining whether they are in equilibrium or not 
(Rodriguez et al. 2009). The statistical test was performed, 
taking into consideration that there were 68 samples in the 
donor population (60 homozygous wildtype phenotypes and 
8 heterozygous phenotypes), and 351 cord blood samples 
(302 homozygous wildtype phenotypes and 49 heterozygous 
phenotypes), with the results depicted in Table 5.
Table 5: HWE statistical calculation for donor and cord blood population
Sample Genotype Expected frequency Observed frequency
n* % n %
Donor population Co(a+b-) 60.24 88.58 60 88.24
Co(a+b+) 7.53 11.07 8 11.76
Co(a-b+) 0.24 0.35 0 0
Cord blood population Co(a+b-) 303.71 86.53 302 86.04
Co(a+b+) 45.58 12.99 49 13.96
Co(a-b+) 1.71 0.49 0 0
Sample p allele frequency** q allele frequency*** p-value (χ2)
Donor population 0.94 0.06 0.27
Cord blood population 0.93 0.07 1.98
*n = count
**p allele frequency = dominant allele frequency (Coa)




As depicted in Table 5, the expected and observed values 
of the phenotypes of the donor and cord blood samples 
respective are approximately the same. Furthermore, the 
p-value of the donor population (0.27) and that of the 
cord blood population (1.98) are greater than the 0.05 level 
of significance, thus outlining that there is no statistical 
difference between the two observed and expected values, 
implying that the populations are within HWE.
5.3 Phenotypic occurrence of the Colton 
blood group in the Maltese population
Complementing the above data, the occurrence of the 
three Colton blood group phenotypes in question within 
the donor pool or cord blood pool was calculated, as seen 
in Table 6.
Table 6: Percentage phenotypic occurrence within the two study populations.




Calculations for phenotypic occurrence explained:
*The allele number was divided by the total number of 
alleles in one study population (calculated by doubling 
the total genotypic number of that population), and 
then multiplied by 100 to convert it to a percentage. For 
instance, Co(a+b-) = 120/(68*2)*100 = 88.23%
6 DISCUSSION
A comparative analysis of the literature bolstering percentage 
occurrences of the Co blood group phenotype within test 
populations was sought to denote any correlations with 
the compiled statistics within the Maltese population. 
Two noteworthy studies were utilised for the scope of this 
preliminary analysis: the previously mentioned study of 
Lewis et al. (1977) that exhibited an observed occurrence 
of Co(a+b-) at 89.81%, Co(a+b+) at 9.78% and Co(a-b+) at 
0.41%; and an ancillary study by Race and Sanger (1975) who 
outlined the percentage occurrence of Co(a+b-) at 91.4%, 
Co(a+b+) at 8.4% and Co(a-b+) at 0.2% within their test 
population.
The data procured from the Maltese samples revealed how 
similar the Co blood group antigen frequency patterns are, 
with an 88.23% and 86.04% occurrence of Co(a+b-) in the 
donor and cord blood populations respectively. The 5.88% 
and 6.98% occurrence of Co(a+b+) in the donor and cord 
blood populations respectively was also quite a similar result, 
albeit slightly lower in comparison. The phenotype Co(a-b+) 
was not encountered in the study, which was still a reflective 
result in comparison to the low percentage occurrences 
found in the other studies. It was also interesting to note 
that this study, which employed a genotyping method, 
yielded comparable results to those published by Lewis et 
al. (1977), who tested samples serologically, using anti-Coa 
and anti-Cob by means of the capillary papain testing.
A closer look at the data obtained from the Maltese 
population samples would indicate that there is no 
significant difference between Co(a+b-) and Co(a+b+) in the 
donor pool and cord blood pool and no statistical difference 
between the phenotypic occurrence in males and females 
in either study populations. Furthermore, both the donor 
populations and the cord blood populations are in HWE, 
indicating that the expected and observed occurrence of 
each phenotype in both population groups are similar.
In order to achieve such results, the serological analysis 
methodology was initially weighed against the Colton 
antigen genotyping methodology. The typical technique for 
serological analysis is haemagglutination, often referred to 
as the “Gold Standard” method, whereby red cell antigens 
are detected through antigen-antibody interactions (Reid 
2009). Studies conducted by both Reid (2009) and Jungbauer 
(2012) outlined the limitations to such a technique for the 
detection of Co blood group antigens due to potentially 
costly testing and feasibility.
In fact, the monoclonal and polyclonal anti-Coa and 
anti-Co3 are exclusively reserved for reference laboratories 
in small quantities, rendering it difficult to choose the 
haemagglutination method. In light of such limitations, it 
was essential to favour the genotyping methods in order to 
enable the typing of Coa and Cob alleles through the 134C>T 
SNP detection, and thus facilitate the identification of the 
Colton phenotypes in question (Halverson & Peyrard, 2010). 
In fact, the utilisation of PCR-ASPE as a means of detecting 
SNPs served as a comprehensive way of amplifying genes that 
express blood group antigens. Moreover, it was a solid basis 
for genotypic and phenotypic classification of blood groups 
(De Mattos 2011). With regards to the specific detection of 
Colton antigens, this method was beneficial since it used 
allele-specific primers, which were previously tested in the 
study by Jungbauer et al. (2011), thus ascertaining that they 
were specific to the alleles in question. In addition to this, 
the previously tested primers shortened the time required to 
optimise the PCR run.
It is worth noting that a number of limitations were 
encountered throughout the study, and were mainly the DNA 
quality and viability, the quantity of samples available and 
aspects of the chosen methodology. The DNA pool included 
a number of old samples that deteriorated in quality and 
integrity due to their exposure to repeated freeze-thaw 
cycles. Furthermore, there was the possibility that some 




period at the National Blood Transfusion. To overcome said 
problems, a number of test repeats were conducted by gel 
electrophoresis on certain samples that gave dubious or 
false negative results. Samples that showed negative results, 
particularly at the HGH band, were discarded. Such a 
situation resulted in a decreased quantity of samples that 
could be successfully tested, which lead to the utilisation of 
a smaller sample size, particularly in the case of the donor 
pool. 
The second limitation was the tedious nature of utilising 
PCR-ASPE, since the Coa and Cob primers were not used 
simultaneously in the same PCR run. In fact, the same DNA 
sample was used twice to test the separate allele mixes, 
therefore indicating that more time and resources were used. 
Another obstacle encountered was the formation of false 
positive bands on the electrophoresis gel, due to non-specific 
amplification of the alleles. This was overcome by repeating 
PCR cycles and increasing the annealing temperature up to 
62ºC, reflecting the finalised annealing temperature. 
The mode of detection of the Co blood group itself posed 
its limitations due to the lack of serological data and limited 
access of anti-sera (Halverson & Peyrard 2010), which would 
have given a clear picture of gene expression and interaction. 
Despite this issue, alternative methodologies were employed 
to achieve the results regardless. 
When taking into consideration such limitations, future 
studies related to the identification of genotypic and allelic 
frequencies of blood group antigens should consider and 
employ alternative techniques such as Sanger sequencing, 
high-throughput sequencing, microarray and multiplex 
technologies instead of PCR-ASPE in order to improve the 
efficiency and quality of results for blood group genotyping.
7 CONCLUSION
A study of this nature has enabled the identification of Coa 
and Cob blood group antigens, the results of which were 
derived from testing a small collection of donor and cord 
blood samples, that were representative of a larger collection 
within the Maltese population. Statistical analysis reveals 
the similarity in frequencies between the binary gender 
segments, the donor and cord blood populations, between 
the Maltese population and other test populations in the 
aforementioned ancillary studies.
The importance of studying the Co blood group has 
already been highlighted due to the association of HTR and 
HDFN occurrence. Apart from mitigating adverse transfusion 
reactions, conducting such testing lays the groundwork for 
increased interdependence between transfusion and genetics, 
ultimately enriching the molecular research database.
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